Literature DB >> 22487769

κ opioid regulation of anxiety-like behavior during acute ethanol withdrawal.

Glenn R Valdez1, Erin Harshberger.   

Abstract

Withdrawal is one of the defining characteristics of alcohol dependence, and is often characterized by impaired physiological function and enhanced negative affect. Recent evidence suggests that the dynorphin (DYN)/kappa opioid receptor (KOR) system may be a key mediator in the negative affect often associated with drugs of abuse. The objective of the present experiments was to determine the role of the DYN/KOR system in the regulation of anxiety-related behavior during acute withdrawal from ethanol. Rats were fed an ethanol liquid diet and following removal, the ability of the KOR antagonist nor-BNI to attenuate the increased anxiogenic-like response characteristic of ethanol withdrawal was investigated using the elevated plus maze. A comparison study was also conducted examining anxiety-related behavior following direct activation of KORs via injections of the KOR agonist U50,488. Rats experiencing ethanol withdrawal showed a significant decrease in open arm exploration compared to controls, an effect that was blocked by nor-BNI. Similar decreases in open arm exploration were observed following injections with the KOR agonist, U50,488, an effect also reversed by pretreatment with nor-BNI. These results suggest that similar mechanisms are involved in the regulation of ethanol withdrawal- and KOR agonist-induced changes in behavior. Given the potential role of enhanced negative affect in persistent ethanol drinking, understanding the role of the DYN/KOR system in regulating anxiety associated with withdrawal may be critical in understanding the factors associated with the nature of alcohol dependence.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487769      PMCID: PMC3354014          DOI: 10.1016/j.pbb.2012.03.019

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  34 in total

1.  Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist.

Authors:  Glenn R Valdez; Eric P Zorrilla; Jean Rivier; Wylie W Vale; George F Koob
Journal:  Brain Res       Date:  2003-08-08       Impact factor: 3.252

2.  Excessive ethanol drinking following a history of dependence: animal model of allostasis.

Authors:  A J Roberts; C J Heyser; M Cole; P Griffin; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-06       Impact factor: 7.853

3.  Time-dependent quantifiable withdrawal from ethanol in the rat: effect of method of dependence induction.

Authors:  D J Macey; G Schulteis; S C Heinrichs; G F Koob
Journal:  Alcohol       Date:  1996 Mar-Apr       Impact factor: 2.405

4.  Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.

Authors:  Jay P McLaughlin; Monica Marton-Popovici; Charles Chavkin
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

5.  Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys.

Authors:  S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

6.  Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.

Authors:  Mark S Todtenkopf; Jacqueline F Marcus; Philip S Portoghese; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2004-01-16       Impact factor: 4.530

7.  Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence.

Authors:  Glenn R Valdez; Eric P Zorrilla; Amanda J Roberts; George F Koob
Journal:  Alcohol       Date:  2003-02       Impact factor: 2.405

8.  Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation.

Authors:  Glenn R Valdez; Valentina Sabino; George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2004-06       Impact factor: 3.455

9.  Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide.

Authors:  Glenn R Valdez; Koki Inoue; George F Koob; Jean Rivier; Wylie Vale; Eric P Zorrilla
Journal:  Brain Res       Date:  2002-07-05       Impact factor: 3.252

10.  Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.

Authors:  Glenn R Valdez; Amanda J Roberts; Karen Chan; Heather Davis; Molly Brennan; Eric P Zorrilla; George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2002-10       Impact factor: 3.455

View more
  32 in total

1.  Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.

Authors:  Kia J Jackson; Asti Jackson; F Ivy Carroll; M Imad Damaj
Journal:  Neuropharmacology       Date:  2015-06-01       Impact factor: 5.250

Review 2.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

Review 3.  Neurochemical mechanisms of alcohol withdrawal.

Authors:  Howard C Becker; Patrick J Mulholland
Journal:  Handb Clin Neurol       Date:  2014

4.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

5.  The kappa opioid receptor modulates GABA neuron excitability and synaptic transmission in midbrainprojections from the insular cortex.

Authors:  Melanie M Pina; Dipanwita Pati; Lara S Hwa; Sarah Y Wu; Alexandra A Mahoney; Chiazam G Omenyi; Montserrat Navarro; Thomas L Kash
Journal:  Neuropharmacology       Date:  2019-12-21       Impact factor: 5.250

Review 6.  Influence of stress associated with chronic alcohol exposure on drinking.

Authors:  Howard C Becker
Journal:  Neuropharmacology       Date:  2017-04-19       Impact factor: 5.250

Review 7.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

8.  Affective cue-induced escalation of alcohol self-administration and increased 22-kHz ultrasonic vocalizations during alcohol withdrawal: role of kappa-opioid receptors.

Authors:  Anthony L Berger; Angela M Williams; Molly M McGinnis; Brendan M Walker
Journal:  Neuropsychopharmacology       Date:  2012-11-06       Impact factor: 7.853

9.  Species differences in the effects of the κ-opioid receptor antagonist zyklophin.

Authors:  Sunil Sirohi; Jane V Aldrich; Brendan M Walker
Journal:  Alcohol       Date:  2016-01-29       Impact factor: 2.405

10.  Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit.

Authors:  Nicole A Crowley; Daniel W Bloodgood; J Andrew Hardaway; Alexis M Kendra; Jordan G McCall; Ream Al-Hasani; Nora M McCall; Waylin Yu; Zachary L Schools; Michael J Krashes; Bradford B Lowell; Jennifer L Whistler; Michael R Bruchas; Thomas L Kash
Journal:  Cell Rep       Date:  2016-03-17       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.